In Vitro Biliary Clearance of Angiotensin II Receptor Blockers and 3-Hydroxy-3-methylglutaryl-Coenzyme A Reductase Inhibitors in Sandwich-Cultured Rat Hepatocytes: Comparison with in Vivo Biliary Clearance
Authors:
- Arlene S. BridgesABArlene S. Bridges
- Wei YueWYWei Yue
- Kim L. R. BrouwerKBKim L. R. Brouwer
- 1 September 2008
- journal article
- research article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 326 (3) , 983-990
Abstract
Previous reports have indicated that in vitro biliary clearance (Clbiliary) determined in sandwich-cultured hepatocytes correlates well with in vivo Clbiliary for limited sets of compounds. This study was designed to estimate the in vitro Clbiliary in sandwich-cultured rat hepatocytes (SCRHs) of angiotensin II receptor blockers and HMG-CoA reductase inhibitors that undergo limited metabolism, to compare the estimated Clbiliary values with published in vivo Clbiliary data in rats, and to characterize the mechanism(s) of basolateral uptake and canalicular excretion of these drugs in rats. The average biliary excretion index (BEI) and in vitro Clbiliary values of olmesartan, valsartan, pravastatin, rosuvastatin, and pitavastatin were 15, 19, 43, 45, and 20%, respectively, and 1.7, 3.2, 4.4, 46.1, and 34.6 ml/min/kg, respectively. Clbiliary predicted from SCRHs, accounting for plasma unbound fraction, correlated with reported in vivo Clbiliary for these drugs. The rank order of Clbiliary values predicted from SCRHs was consistent with in vivo Clbiliary values. Bromosulfophthalein inhibited the uptake of all drugs. BEI and Clbiliary values of olmesartan, valsartan, pravastatin, and rosuvastatin, known multidrug resistance-associated protein (Mrp) 2 substrates, were reduced in SCRHs from Mrp2-deficient (TR-) compared with wild-type (WT) rats. Although Mrp2 plays a minor role in pitavastatin biliary excretion, pitavastatin BEI and Clbiliary were reduced in TR- compared with WT SCRHs; Bcrp expression in SCRHs from TR- rats was decreased. In conclusion, in vitro Clbiliary determined in SCRHs can be used to estimate and compare in vivo Clbiliary of compounds in rats and to characterize transport proteins responsible for their hepatic uptake and excretion.Keywords
This publication has 36 references indexed in Scilit:
- Effect of Plasma Protein Binding on in Vitro-in Vivo Correlation of Biliary Excretion of Drugs Evaluated by Sandwich-Cultured Rat HepatocytesDrug Metabolism and Disposition, 2008
- Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in Freshly Isolated Rat HepatocytesDrug Metabolism and Disposition, 2008
- IN VITRO AND IN VIVO CORRELATION OF HEPATIC TRANSPORTER EFFECTS ON ERYTHROMYCIN METABOLISM: CHARACTERIZING THE IMPORTANCE OF TRANSPORTER-ENZYME INTERPLAYDrug Metabolism and Disposition, 2006
- Hepatobiliary Disposition of a Drug/Metabolite Pair: Comprehensive Pharmacokinetic Modeling in Sandwich-Cultured Rat HepatocytesThe Journal of Pharmacology and Experimental Therapeutics, 2006
- INVOLVEMENT OF TRANSPORTERS IN THE HEPATIC UPTAKE AND BILIARY EXCRETION OF VALSARTAN, A SELECTIVE ANTAGONIST OF THE ANGIOTENSIN II AT1-RECEPTOR, IN HUMANSDrug Metabolism and Disposition, 2006
- The importance of early antihypertensive efficacy: the role of angiotensin II receptor blocker therapyJournal of Human Hypertension, 2006
- Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductaseJournal of Pharmacy and Pharmacology, 2005
- Involvement of BCRP (ABCG2) in the Biliary Excretion of PitavastatinMolecular Pharmacology, 2005
- Role of Glycosylation in Trafficking of Mrp2 in Sandwich-Cultured Rat HepatocytesMolecular Pharmacology, 2005
- Uptake of rosuvastatin by isolated rat hepatocytes: comparison with pravastatinXenobiotica, 2003